- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
The University of Texas MD Anderson Cancer Center | Strategic Alliance Partners
Latest from The University of Texas MD Anderson Cancer Center
Dr. Lee on Cirmtuzumab/Ibrutinib Dosing in MCL and CLL
June 03, 2020
Video
Hun Ju Lee, MD, discusses dosing of the combination of the investigational ROR1 inhibitor cirmtuzumab and ibrutinib in mantle cell lymphoma and chronic lymphocytic leukemia.
Dr. DiNardo on the Role of Venetoclax in AML
June 03, 2020
Video
Courtney DiNardo, MD, MSCE, discusses the role of venetoclax (Venclexta) in acute myeloid leukemia (AML).
Dr. Overman on Potential Application of ctDNA in CRC
June 02, 2020
Video
Michael J. Overman, MD, discusses potential applications for circulating tumor DNA in colorectal cancer.
Dr. Mizrahi on Targeting Treatment in Metastatic Colorectal Cancer
May 28, 2020
Video
Jonathan Mizrahi, MD, discusses efforts being made to target treatment for patients with metastatic colorectal cancer.
Dr. Smaglo on the Role of Immunotherapy in Advanced Gastric Cancer
May 27, 2020
Video
Brandon G. Smaglo, MD, FACP, discusses the role of immunotherapy in advanced gastric cancer.
Dr. Le on Research Needed to Address Unmet Needs in mCRC
May 27, 2020
Video
Phat Le, MD, discusses research efforts that are needed to address unmet needs in metastatic colorectal cancer.
Dr. Raghav on the Utility of ctDNA in CRC
May 27, 2020
Video
Kanwal Raghav, MBBS, MD, discusses the utility of circulating tumor DNA in colorectal cancer.
Dr. Jain on Next Steps for Venetoclax in Relapsed MCL
May 22, 2020
Video
Preetesh Jain, MD, PhD, discusses the next steps for a study examining the efficacy of venetoclax in high risk relapsed mantle cell lymphoma.
Dr. Nelson on Why Patients With mCRC are Often Referred to Surgeons First
May 22, 2020
Video
Douglas A. Nelson, MD, discusses why patients with metastatic colorectal cancer are often referred to surgeons before medical oncologists.
Dr. Nelson on Why Patients With mCRC are Often Referred to Surgeons First
May 21, 2020
Video
Douglas A. Nelson, MD, discusses why patients with metastatic colorectal cancer are often referred to surgeons before medical oncologists.
Dr. Subbiah on the Utility of Tivozanib in RCC
May 20, 2020
Video
Vivek Subbiah, MD, discusses the utility of tivozanib in renal cell carcinoma.
Dr. Jain on Response and Resistance to Venetoclax in Relapsed/Refractory MCL
May 20, 2020
Video
Preetesh Jain, MD, PhD, discusses response and resistance to venetoclax (Venclexta) in relapsed/refractory mantle cell lymphoma (MCL).
Dr. Morris on the Role of Immunotherapy in Metastatic CRC
May 20, 2020
Video
Van K. Morris, MD, discusses the role of immunotherapy in metastatic colorectal cancer.
Venetoclax Shows Marked Responses and Distinct Resistance Mechanisms in MCL
May 19, 2020
Article
Preetesh Jain, MD, PhD, evaluates mechanisms of resistance to venetoclax in patients with heavily pretreated mantle cell lymphoma and the next phase of this research.
Dr. Morris on the Role of Immunotherapy in Metastatic CRC
May 19, 2020
Video
Van K. Morris, MD, discusses the role of immunotherapy in metastatic colorectal cancer.
Venetoclax Shows Marked Responses and Distinct Resistance Mechanisms in MCL
May 19, 2020
Article
Preetesh Jain, MD, PhD, evaluated mechanisms of resistance to venetoclax in patients with heavily pretreated mantle cell lymphoma and the next phase of this research.
Dr. Wang on Research Trends in MCL
May 16, 2020
Video
Michael Wang, MD, discusses research trends in mantle cell lymphoma (MCL).
Dr. Lilenbaum on the Rise of Immunotherapy in NSCLC
May 16, 2020
Video
Rogerio C. Lilenbaum, MD, discusses the rise of immunotherapy in non–small cell lung cancer.
Dr. Lilenbaum on the Rise of Immunotherapy in NSCLC
May 15, 2020
Video
Rogerio C. Lilenbaum, MD, discusses the rise of immunotherapy in non–small cell lung cancer.
Dr. Daver on Anticipated Breakthroughs in AML
May 15, 2020
Video
Naval G. Daver, MD, discusses anticipated breakthroughs in acute myeloid leukemia (AML).